Q-omics provides the consensus-scored ELN-AS1 profile across patient tissues and cancer cell-line models. ELN-AS1 expression is associated with patient survival in 26 of 34 cancer types, with the highest sampling consensus in BRCA. Among the 18 cancer types available for tumor–normal comparison, ELN-AS1 is differentially expressed in 13, with the highest sampling consensus in THCA. Additionally, ELN-AS1 RNA expression shows 15,671 significant protein co-abundance associations, with the highest sampling consensus in BRCA. Together, these results highlight BRCA, and THCA as cancer lineages where ELN-AS1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for ELN-AS1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes ELN-AS1 survival associations across molecular data types. ELN-AS1 RNA expression shows survival associations in the most cancer types (26). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible ELN-AS1 RNA expression–survival associations across cancer types. High ELN-AS1 expression shows unfavorable associations in GBM, KIRC and LGG, but favorable associations in BRCA, UCEC and UCS. The BRCA Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify BRCA as the clearest survival context for ELN-AS1 RNA expression.
This table summarizes ELN-AS1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 13. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for ELN-AS1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. ELN-AS1 shows lower tumor expression in THCA, KIRC, LUSC, KICH, BLCA and LUAD. The THCA box plot shows higher ELN-AS1 RNA expression in normal versus tumor tissue (log2 FC = −2.412, t-test p < 0.001).
This table shows molecular features associated with ELN-AS1 in patient tissues and cancer cell lines. In patient samples, ELN-AS1 shows the broadest associations at the RNA and protein expression levels, with BRCA recurring as the lineage with the largest associated feature set.
